These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 37331504)

  • 41. Pharmacological inhibition of Vanin-1 is not protective in models of acute and chronic kidney disease.
    Unterschemmann K; Ehrmann A; Herzig I; Andreevski AL; Lustig K; Schmeck C; Eitner F; Grundmann M
    Am J Physiol Renal Physiol; 2021 Jan; 320(1):F61-F73. PubMed ID: 33196323
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Galectin-8 counteracts folic acid-induced acute kidney injury and prevents its transition to fibrosis.
    Perez-Moreno E; Toledo T; Campusano P; Zuñiga S; Azócar L; Feuerhake T; Méndez GP; Labarca M; Pérez-Molina F; de la Peña A; Herrera-Cid C; Ehrenfeld P; Godoy AS; González A; Soza A
    Biomed Pharmacother; 2024 Aug; 177():116923. PubMed ID: 38936192
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Akt1 is involved in renal fibrosis and tubular apoptosis in a murine model of acute kidney injury-to-chronic kidney disease transition.
    Kim IY; Song SH; Seong EY; Lee DW; Bae SS; Lee SB
    Exp Cell Res; 2023 Mar; 424(2):113509. PubMed ID: 36773738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of contralateral nephrectomy timing and ischemic conditions on kidney fibrosis after unilateral kidney ischemia-reperfusion injury.
    Zhang J; Shen R; Lin H; Pan J; Feng X; Lin L; Niu D; Hou Y; Su X; Wang C; Wang L; Qiao X
    Ren Fail; 2022 Dec; 44(1):1568-1584. PubMed ID: 36154902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis.
    Chen DQ; Feng YL; Chen L; Liu JR; Wang M; Vaziri ND; Zhao YY
    Free Radic Biol Med; 2019 Apr; 134():484-497. PubMed ID: 30716432
    [TBL] [Abstract][Full Text] [Related]  

  • 46. GSDMD and GSDME synergy in the transition of acute kidney injury to chronic kidney disease.
    Chen Z; Chen C; Lai K; Wu C; Wu F; Chen Z; Ye K; Xie J; Ma H; Chen H; Wang Y; Xu Y
    Nephrol Dial Transplant; 2024 Jul; 39(8):1344-1359. PubMed ID: 38244230
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antithrombin III prevents progression of chronic kidney disease following experimental ischaemic-reperfusion injury.
    Yin J; Wang F; Kong Y; Wu R; Zhang G; Wang N; Wang L; Lu Z; Liang M
    J Cell Mol Med; 2017 Dec; 21(12):3506-3514. PubMed ID: 28767184
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypoxic mesenchymal stem cells ameliorate acute kidney ischemia-reperfusion injury via enhancing renal tubular autophagy.
    Tseng WC; Lee PY; Tsai MT; Chang FP; Chen NJ; Chien CT; Hung SC; Tarng DC
    Stem Cell Res Ther; 2021 Jun; 12(1):367. PubMed ID: 34183058
    [TBL] [Abstract][Full Text] [Related]  

  • 49. LTBP4 Protects Against Renal Fibrosis via Mitochondrial and Vascular Impacts.
    Su CT; See DHW; Huang YJ; Jao TM; Liu SY; Chou CY; Lai CF; Lin WC; Wang CY; Huang JW; Hung KY
    Circ Res; 2023 Jun; 133(1):71-85. PubMed ID: 37232163
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhancer of zeste homolog 2 promotes renal fibrosis after acute kidney injury by inducing epithelial-mesenchymal transition and activation of M2 macrophage polarization.
    Zhou X; Chen H; Hu Y; Ma X; Li J; Shi Y; Tao M; Wang Y; Zhong Q; Yan D; Zhuang S; Liu N
    Cell Death Dis; 2023 Apr; 14(4):253. PubMed ID: 37029114
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subcellular trafficking of tubular MDM2 implicates in acute kidney injury to chronic kidney disease transition during multiple low-dose cisplatin exposure.
    Su H; Ye C; Lei CT; Tang H; Zeng JY; Yi F; Zhang C
    FASEB J; 2020 Jan; 34(1):1620-1636. PubMed ID: 31914692
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progression of Chronic Kidney Disease After Acute Kidney Injury: Role of Self-Perpetuating Versus Hemodynamic-Induced Fibrosis.
    Picken M; Long J; Williamson GA; Polichnowski AJ
    Hypertension; 2016 Oct; 68(4):921-8. PubMed ID: 27550923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of SIK1 in the transition of acute kidney injury into chronic kidney disease.
    Hu J; Qiao J; Yu Q; Liu B; Zhen J; Liu Y; Ma Q; Li Y; Wang Q; Wang C; Lv Z
    J Transl Med; 2021 Feb; 19(1):69. PubMed ID: 33588892
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Short-term dexamethasone treatment transiently, but not permanently, attenuates fibrosis after acute-to-chronic kidney injury.
    Moonen L; Geryl H; D'Haese PC; Vervaet BA
    BMC Nephrol; 2018 Dec; 19(1):343. PubMed ID: 30509215
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of Xanthine Oxidase Protects against Sepsis-Induced Acute Kidney Injury by Ameliorating Renal Hypoxia.
    Wang TT; Du YW; Wang W; Li XN; Liu HB
    Oxid Med Cell Longev; 2022; 2022():4326695. PubMed ID: 35873795
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-anemia drug FG4592 retards the AKI-to-CKD transition by improving vascular regeneration and antioxidative capability.
    Wu M; Chen W; Miao M; Jin Q; Zhang S; Bai M; Fan J; Zhang Y; Zhang A; Jia Z; Huang S
    Clin Sci (Lond); 2021 Jul; 135(14):1707-1726. PubMed ID: 34255035
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel pharmacological effects of lecithinized superoxide dismutase on ischemia/reperfusion injury in the kidneys of mice.
    Tanaka KI; Shimoda M; Kubota M; Takafuji A; Kawahara M; Mizushima T
    Life Sci; 2022 Jan; 288():120164. PubMed ID: 34822794
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Persistent oxidative stress following renal ischemia-reperfusion injury increases ANG II hemodynamic and fibrotic activity.
    Basile DP; Leonard EC; Beal AG; Schleuter D; Friedrich J
    Am J Physiol Renal Physiol; 2012 Jun; 302(11):F1494-502. PubMed ID: 22442209
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early elimination of uremic toxin ameliorates AKI-to-CKD transition.
    Chen JH; Chao CT; Huang JW; Hung KY; Liu SH; Tarng DC; Chiang CK
    Clin Sci (Lond); 2021 Dec; 135(23):2643-2658. PubMed ID: 34796904
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hippo-YAP/MCP-1 mediated tubular maladaptive repair promote inflammation in renal failed recovery after ischemic AKI.
    Zheng Z; Li C; Shao G; Li J; Xu K; Zhao Z; Zhang Z; Liu J; Wu H
    Cell Death Dis; 2021 Jul; 12(8):754. PubMed ID: 34330891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.